POLYNOVO LIMITED - Announcements

Market Cap $1.414B Add to my watchlist

Healthcare Medical Instruments & Supplies

PolyNovo Limited is an Australia-based company, which is engaged in the development of... PolyNovo Limited is an Australia-based company, which is engaged in the development of medical devices for various medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM product is designed to help surgeons treat traumatic wounds. NovoSorb BTM may be used to temporarily close the wound and aid the body in generating new tissue. It is indicated for full or deep partial-thickness burns, surgical and reconstructive wounds and traumatic wounds. BTM is applied to a wound once the unhealthy or dead tissue has been surgically removed. NovoSorb is a medical-grade polymers that can be expressed in a range of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products.More

Announcements

Filter Results

All Price Sensitive Only

PNV	Victorian Government Grant for Expansion of R&D Facility		26/04/24	284.51KB	Share
PNV	Notification regarding unquoted securities - PNV		10/04/24	15.48KB	Share
PNV	India update	PRICE SENSITIVE	04/03/24	280.08KB	Share
PNV	Webcast Recording - 1H24 Results		28/02/24	223.11KB	Share
PNV	1H FY24 Results Presentation	PRICE SENSITIVE	27/02/24	1.12MB	Share
PNV	Appendix 4D & 1H FY24 Report	PRICE SENSITIVE	27/02/24	2.12MB	Share
PNV	Largest ever single order		16/02/24	283.13KB	Share
PNV	Webcast Details - 1H24 Results		15/02/24	223.65KB	Share
PNV	1H24 Trading Result (unaudited)	PRICE SENSITIVE	22/01/24	294.82KB	Share
PNV	PolyNovo presents at Annual J.P. Morgan Heathcare Conference		10/01/24	1.34MB	Share
PNV	First $A8M sales month and $A9M revenue month	PRICE SENSITIVE	06/12/23	695.89KB	Share
PNV	Chairman address to Bell Potter Healthcare Conference		15/11/23	211.14KB	Share
PNV	AGM 2023 - Webcast Recording		07/11/23	253.98KB	Share
PNV	Voting Results - 2023 AGM		03/11/23	299.08KB	Share
PNV	AGM - Chairman and CEO address to shareholders	PRICE SENSITIVE	03/11/23	285.21KB	Share
PNV	Director Share Purchase - Robyn Elliott		03/11/23	274.19KB	Share
PNV	PolyNovo presents at Wilsons Drug and Device Conference		26/10/23	1.46MB	Share
PNV	Notice of Meeting - Correction to Directors Bio		04/10/23	248.43KB	Share
PNV	Notice of Meeting		02/10/23	319.73KB	Share
PNV	BARDA increases funding US$10M	PRICE SENSITIVE	02/10/23	297KB	Share
PNV	YTD August 2023 Trading Update	PRICE SENSITIVE	25/09/23	302.79KB	Share
PNV	Trading Halt	PRICE SENSITIVE	25/09/23	138.1KB	Share
PNV	Annual Report 2023		13/09/23	5.1MB	Share
PNV	PolyNovo presents at Evans & Partners Healthcare Conference		12/09/23	1.46MB	Share
PNV	Webcast Recording - FY23 Results		31/08/23	240.4KB	Share
PNV	Corporate Governance Statement		24/08/23	163.64KB	Share
PNV	Appendix 4G		24/08/23	291.17KB	Share
PNV	FY23 Results Presentation	PRICE SENSITIVE	23/08/23	769.19KB	Share
PNV	Appendix 4E and FY23 Financial Statements	PRICE SENSITIVE	23/08/23	1.94MB	Share
PNV	Webcast Details - FY23 Results		11/08/23	235.43KB	Share
PNV	Appendix 3Y - Robyn Elliott		30/06/23	273.9KB	Share
PNV	Director Share Purchase - David Williams		08/06/23	259.9KB	Share
PNV	Director Share Purchase - David Williams		08/06/23	259.82KB	Share
PNV	First ever A$7M Sales Month	PRICE SENSITIVE	07/06/23	305.64KB	Share
PNV	Trading Halt	PRICE SENSITIVE	06/06/23	256.72KB	Share
PNV	Pause in Trading	PRICE SENSITIVE	06/06/23	116.29KB	Share
PNV	Notification regarding unquoted securities - PNV		31/05/23	25.2KB	Share
PNV	PolyNovo presents at Macquarie Australia Conference		03/05/23	989.36KB	Share
PNV	NovoSorb MTX First Sales and March 2023 $6m Revenue	PRICE SENSITIVE	02/05/23	310.66KB	Share
PNV	Trading Halt	PRICE SENSITIVE	01/05/23	255.28KB	Share
PNV	Application for quotation of securities - PNV		31/03/23	25.17KB	Share
PNV	Change of Director's Interest Notice		23/03/23	414.72KB	Share
PNV	Application for quotation of securities - PNV		16/03/23	25.18KB	Share
PNV	S&P DJI Announces March 2023 Quarterly Rebalance	PRICE SENSITIVE	03/03/23	128.97KB	Share
PNV	1H FY23 Results - Webcast Recording		01/03/23	241.51KB	Share
PNV	PolyNovo presents at Macquarie Bank		24/02/23	402.69KB	Share
PNV	1H FY23 Results Presentation	PRICE SENSITIVE	23/02/23	559.68KB	Share
PNV	Appendix 4D and 1H FY23 Report	PRICE SENSITIVE	23/02/23	4.01MB	Share
PNV	Appendix 3Y - Robyn Elliott		22/02/23	273.72KB	Share
PNV	Appendix 3Y - Christine Emmanuel		22/02/23	274.75KB	Share
PNV	Appendix 3Y - Andrew Lumsden		22/02/23	274.79KB	Share
PNV	Appendix 3Y - Bruce Rathie		22/02/23	274.47KB	Share
PNV	Appendix 3Y - David Williams		22/02/23	260.06KB	Share
PNV	Cleansing Notice		16/02/23	192.49KB	Share
PNV	Application for quotation of securities - PNV		15/02/23	23.12KB	Share
PNV	Update - SynPath Diabetic Foot Ulcer Trial		15/02/23	170.87KB	Share
PNV	Webcast details - 1HFY23 Results		14/02/23	152.4KB	Share
PNV	Results of General Meeting		17/01/23	294.85KB	Share
PNV	1H23 Indicative Trading Result (unaudited)	PRICE SENSITIVE	16/01/23	301.28KB	Share
PNV	Presentation slides - J.P. Morgan Healthcare Conference		11/01/23	1.36MB	Share
PNV	Presentation to J.P. Morgan Healthcare Conference		10/01/23	236.29KB	Share
PNV	Application for quotation of securities - PNV		19/12/22	23.33KB	Share
PNV	Successful Completion of Share Purchase Plan	PRICE SENSITIVE	16/12/22	297.22KB	Share
PNV	Webcast Recording - Investor Presentation and Update		07/12/22	212.84KB	Share
PNV	Notice of General Meeting		07/12/22	325.11KB	Share
PNV	Webcast Agenda - Investor Presentation and Update		05/12/22	361.4KB	Share
PNV	Amended Weblink - Investor Presentation & Update 5 Dec 2022		02/12/22	266.43KB	Share
PNV	Investor Presentation & Update - Webcast 5 Dec 2022		02/12/22	266.4KB	Share
PNV	Share Purchase Plan (SPP) Offer	PRICE SENSITIVE	30/11/22	475.6KB	Share
PNV	Cleansing Notice		29/11/22	192.7KB	Share
PNV	Application for quotation of securities - PNV		28/11/22	23.53KB	Share
PNV	Ceasing to be a substantial holder		23/11/22	699.79KB	Share
PNV	Completion of $30m Institutional Placement	PRICE SENSITIVE	23/11/22	320.5KB	Share
PNV	Proposed issue of securities - PNV		22/11/22	35.24KB	Share
PNV	Investor Presentation	PRICE SENSITIVE	22/11/22	1.31MB	Share
PNV	Capital Raising	PRICE SENSITIVE	22/11/22	218.48KB	Share
PNV	Trading Halt	PRICE SENSITIVE	22/11/22	256.24KB	Share
PNV	Chairman's address at Bell Potter Healthcare Conference		10/11/22	332.21KB	Share
PNV	PolyNovo enters India market		07/11/22	301.25KB	Share
PNV	AGM 2022 - Webcast Recording		04/11/22	238.38KB	Share
PNV	Results of 2022 Annual General Meeting		28/10/22	306.22KB	Share
PNV	Chairman and CEO - AGM address to shareholders	PRICE SENSITIVE	28/10/22	326.28KB	Share
PNV	Hong Kong - Two cases, Two surgeons		26/10/22	297.13KB	Share
PNV	Canada - NovoSorb BTM registration approved		25/10/22	295.69KB	Share
PNV	Director Share Purchase - David Williams		17/10/22	180.31KB	Share
PNV	Director Share Purchase - David Williams		14/10/22	180.34KB	Share
PNV	Director Share Purchase - David Williams		13/10/22	180.25KB	Share
PNV	Director Share Purchase - David Williams		11/10/22	180.29KB	Share
PNV	Director Share Purchase - David Williams		10/10/22	180.26KB	Share
PNV	Q1 FY23 Sales Result	PRICE SENSITIVE	06/10/22	303.55KB	Share
PNV	Notice of Annual General Meeting		27/09/22	405.38KB	Share
PNV	Annual Report 2022		21/09/22	6.57MB	Share
PNV	Becoming a substantial holder		21/09/22	900.9KB	Share
PNV	FDA 510(k) clearance for NovoSorb MTX	PRICE SENSITIVE	19/09/22	185.25KB	Share
PNV	Trading halt	PRICE SENSITIVE	16/09/22	142.63KB	Share
PNV	Pause in trading	PRICE SENSITIVE	16/09/22	115.9KB	Share
PNV	Final Director's Interest Notice		07/09/22	243.73KB	Share
PNV	Director resignation & appointment Chief Tech & Sci Officer		01/09/22	277.47KB	Share
PNV	PolyNovo FY22 Briefing Session	PRICE SENSITIVE	26/08/22	377.09KB	Share
PNV	Corporate Governance Statement		26/08/22	162.52KB	Share

PNV Victorian Government Grant for Expansion of R&D Facility
26/04/24		284.51KB	Share
PNV Notification regarding unquoted securities - PNV
10/04/24		15.48KB	Share
PNV India update
04/03/24	PRICE SENSITIVE	280.08KB	Share
PNV Webcast Recording - 1H24 Results
28/02/24		223.11KB	Share
PNV 1H FY24 Results Presentation
27/02/24	PRICE SENSITIVE	1.12MB	Share
PNV Appendix 4D & 1H FY24 Report
27/02/24	PRICE SENSITIVE	2.12MB	Share
PNV Largest ever single order
16/02/24		283.13KB	Share
PNV Webcast Details - 1H24 Results
15/02/24		223.65KB	Share
PNV 1H24 Trading Result (unaudited)
22/01/24	PRICE SENSITIVE	294.82KB	Share
PNV PolyNovo presents at Annual J.P. Morgan Heathcare Conference
10/01/24		1.34MB	Share
PNV First $A8M sales month and $A9M revenue month
06/12/23	PRICE SENSITIVE	695.89KB	Share
PNV Chairman address to Bell Potter Healthcare Conference
15/11/23		211.14KB	Share
PNV AGM 2023 - Webcast Recording
07/11/23		253.98KB	Share
PNV Voting Results - 2023 AGM
03/11/23		299.08KB	Share
PNV AGM - Chairman and CEO address to shareholders
03/11/23	PRICE SENSITIVE	285.21KB	Share
PNV Director Share Purchase - Robyn Elliott
03/11/23		274.19KB	Share
PNV PolyNovo presents at Wilsons Drug and Device Conference
26/10/23		1.46MB	Share
PNV Notice of Meeting - Correction to Directors Bio
04/10/23		248.43KB	Share
PNV Notice of Meeting
02/10/23		319.73KB	Share
PNV BARDA increases funding US$10M
02/10/23	PRICE SENSITIVE	297KB	Share
PNV YTD August 2023 Trading Update
25/09/23	PRICE SENSITIVE	302.79KB	Share
PNV Trading Halt
25/09/23	PRICE SENSITIVE	138.1KB	Share
PNV Annual Report 2023
13/09/23		5.1MB	Share
PNV PolyNovo presents at Evans & Partners Healthcare Conference
12/09/23		1.46MB	Share
PNV Webcast Recording - FY23 Results
31/08/23		240.4KB	Share
PNV Corporate Governance Statement
24/08/23		163.64KB	Share
PNV Appendix 4G
24/08/23		291.17KB	Share
PNV FY23 Results Presentation
23/08/23	PRICE SENSITIVE	769.19KB	Share
PNV Appendix 4E and FY23 Financial Statements
23/08/23	PRICE SENSITIVE	1.94MB	Share
PNV Webcast Details - FY23 Results
11/08/23		235.43KB	Share
PNV Appendix 3Y - Robyn Elliott
30/06/23		273.9KB	Share
PNV Director Share Purchase - David Williams
08/06/23		259.9KB	Share
PNV Director Share Purchase - David Williams
08/06/23		259.82KB	Share
PNV First ever A$7M Sales Month
07/06/23	PRICE SENSITIVE	305.64KB	Share
PNV Trading Halt
06/06/23	PRICE SENSITIVE	256.72KB	Share
PNV Pause in Trading
06/06/23	PRICE SENSITIVE	116.29KB	Share
PNV Notification regarding unquoted securities - PNV
31/05/23		25.2KB	Share
PNV PolyNovo presents at Macquarie Australia Conference
03/05/23		989.36KB	Share
PNV NovoSorb MTX First Sales and March 2023 $6m Revenue
02/05/23	PRICE SENSITIVE	310.66KB	Share
PNV Trading Halt
01/05/23	PRICE SENSITIVE	255.28KB	Share
PNV Application for quotation of securities - PNV
31/03/23		25.17KB	Share
PNV Change of Director's Interest Notice
23/03/23		414.72KB	Share
PNV Application for quotation of securities - PNV
16/03/23		25.18KB	Share
PNV S&P DJI Announces March 2023 Quarterly Rebalance
03/03/23	PRICE SENSITIVE	128.97KB	Share
PNV 1H FY23 Results - Webcast Recording
01/03/23		241.51KB	Share
PNV PolyNovo presents at Macquarie Bank
24/02/23		402.69KB	Share
PNV 1H FY23 Results Presentation
23/02/23	PRICE SENSITIVE	559.68KB	Share
PNV Appendix 4D and 1H FY23 Report
23/02/23	PRICE SENSITIVE	4.01MB	Share
PNV Appendix 3Y - Robyn Elliott
22/02/23		273.72KB	Share
PNV Appendix 3Y - Christine Emmanuel
22/02/23		274.75KB	Share
PNV Appendix 3Y - Andrew Lumsden
22/02/23		274.79KB	Share
PNV Appendix 3Y - Bruce Rathie
22/02/23		274.47KB	Share
PNV Appendix 3Y - David Williams
22/02/23		260.06KB	Share
PNV Cleansing Notice
16/02/23		192.49KB	Share
PNV Application for quotation of securities - PNV
15/02/23		23.12KB	Share
PNV Update - SynPath Diabetic Foot Ulcer Trial
15/02/23		170.87KB	Share
PNV Webcast details - 1HFY23 Results
14/02/23		152.4KB	Share
PNV Results of General Meeting
17/01/23		294.85KB	Share
PNV 1H23 Indicative Trading Result (unaudited)
16/01/23	PRICE SENSITIVE	301.28KB	Share
PNV Presentation slides - J.P. Morgan Healthcare Conference
11/01/23		1.36MB	Share
PNV Presentation to J.P. Morgan Healthcare Conference
10/01/23		236.29KB	Share
PNV Application for quotation of securities - PNV
19/12/22		23.33KB	Share
PNV Successful Completion of Share Purchase Plan
16/12/22	PRICE SENSITIVE	297.22KB	Share
PNV Webcast Recording - Investor Presentation and Update
07/12/22		212.84KB	Share
PNV Notice of General Meeting
07/12/22		325.11KB	Share
PNV Webcast Agenda - Investor Presentation and Update
05/12/22		361.4KB	Share
PNV Amended Weblink - Investor Presentation & Update 5 Dec 2022
02/12/22		266.43KB	Share
PNV Investor Presentation & Update - Webcast 5 Dec 2022
02/12/22		266.4KB	Share
PNV Share Purchase Plan (SPP) Offer
30/11/22	PRICE SENSITIVE	475.6KB	Share
PNV Cleansing Notice
29/11/22		192.7KB	Share
PNV Application for quotation of securities - PNV
28/11/22		23.53KB	Share
PNV Ceasing to be a substantial holder
23/11/22		699.79KB	Share
PNV Completion of $30m Institutional Placement
23/11/22	PRICE SENSITIVE	320.5KB	Share
PNV Proposed issue of securities - PNV
22/11/22		35.24KB	Share
PNV Investor Presentation
22/11/22	PRICE SENSITIVE	1.31MB	Share
PNV Capital Raising
22/11/22	PRICE SENSITIVE	218.48KB	Share
PNV Trading Halt
22/11/22	PRICE SENSITIVE	256.24KB	Share
PNV Chairman's address at Bell Potter Healthcare Conference
10/11/22		332.21KB	Share
PNV PolyNovo enters India market
07/11/22		301.25KB	Share
PNV AGM 2022 - Webcast Recording
04/11/22		238.38KB	Share
PNV Results of 2022 Annual General Meeting
28/10/22		306.22KB	Share
PNV Chairman and CEO - AGM address to shareholders
28/10/22	PRICE SENSITIVE	326.28KB	Share
PNV Hong Kong - Two cases, Two surgeons
26/10/22		297.13KB	Share
PNV Canada - NovoSorb BTM registration approved
25/10/22		295.69KB	Share
PNV Director Share Purchase - David Williams
17/10/22		180.31KB	Share
PNV Director Share Purchase - David Williams
14/10/22		180.34KB	Share
PNV Director Share Purchase - David Williams
13/10/22		180.25KB	Share
PNV Director Share Purchase - David Williams
11/10/22		180.29KB	Share
PNV Director Share Purchase - David Williams
10/10/22		180.26KB	Share
PNV Q1 FY23 Sales Result
06/10/22	PRICE SENSITIVE	303.55KB	Share
PNV Notice of Annual General Meeting
27/09/22		405.38KB	Share
PNV Annual Report 2022
21/09/22		6.57MB	Share
PNV Becoming a substantial holder
21/09/22		900.9KB	Share
PNV FDA 510(k) clearance for NovoSorb MTX
19/09/22	PRICE SENSITIVE	185.25KB	Share
PNV Trading halt
16/09/22	PRICE SENSITIVE	142.63KB	Share
PNV Pause in trading
16/09/22	PRICE SENSITIVE	115.9KB	Share
PNV Final Director's Interest Notice
07/09/22		243.73KB	Share
PNV Director resignation & appointment Chief Tech & Sci Officer
01/09/22		277.47KB	Share
PNV PolyNovo FY22 Briefing Session
26/08/22	PRICE SENSITIVE	377.09KB	Share
PNV Corporate Governance Statement
26/08/22		162.52KB	Share

REFRESH

1 2 3 4

(20min delay)
Last $2.05		Change 0.040(1.99%)		Mkt cap ! $1.414B

Open	High	Low	Value	Volume
$2.03	$2.06	$2.03	$289.7K	142.1K

Buyers (Bids)

No.	Vol.	Price($)
18	4510	$2.04

Sellers (Offers)

Price($)	Vol.	No.
$2.05	19240	14

View Market Depth

No.	Vol.	Price($)
11	4145	2.040
21	31324	2.030
20	40973	2.020
15	22344	2.010
11	55940	2.000

Price($)	Vol.	No.
2.050	19740	15
2.060	60008	19
2.070	38071	15
2.080	64225	12
2.090	38322	6

Last trade - 10.44am 02/05/2024 (20 minute delay)


Last $2.05		Change 0.040 ( 1.64 %)
Open	High	Low	Volume
$2.03	$2.06	$2.03	62077
Last updated 11.04am 02/05/2024 ?

PNV (ASX) Chart

POLYNOVO LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories